Alexion to acquire Synageva for $8.4 Billion

By: Pharma Tips | Views: 1050 | Date: 15-May-2015

Alexion Pharmaceuticals will acquire Synageva BioPharma Corporation for $8.4 billion in cash and stock to develop in the field of rare-disease treatments. The company said in a statement that Alexion Pharmaceuticals will offer $115 in cash and 0.6581 Alexion shares for each share of Synageva.

Alexion to acquire Synageva for $8.4 billion

Alexion Pharmaceuticals will acquire Synageva BioPharma Corporation for $8.4 billion in cash and stock to develop in the field of rare-disease treatments. The company said in a statement that Alexion Pharmaceuticals will offer $115 in cash and 0.6581 Alexion shares for each share of Synageva.

It also said that it indicates a share value of $230 based on the nine day volume-weighted average closing price of Alexion stock through May 5, 2015. The boards of both the companies have supported the transaction.


A medicine called Soliris was developed by Alexion, which led to a sale of $2 billion last year. The medicine was developed for patients with two rare but life-threatening disorders. Synageva also looks forward to developing such drugs together with a medicine called Kanuma.

David Hallal, Chief Executive Officer of Alexion, said in the statement, "Synageva is an ideal strategic and operational fit for Alexion that aligns with what we know well and do well -- providing life-transforming therapies to an increasing number of patients with devastating and rare diseases".

Synageva shares rose by over 125% in pre-market trade on Wednesday. Alexion's shares declined by almost 3 per cent.

Previous Page Next Page

People Searching On This Page:

Related Pages


Sun Pharma to acquire US-based InSite Vision for $48 million

Sun Pharma to acquire US-based InSite Vision for $48 million

News | Pharma Companies
Date:
19-Sep-2015  Views: 4559

Mumbai: One of the subsidiaries of Sun Pharmaceutical Industries Ltd, the largest Indian drugmaker, has entered into an agreement to acquire US-based ...
Lupin acquires US based Gavis Pharma for $880 million

Lupin acquires US based Gavis Pharma for $880 million

News | Pharma Companies
Date:
31-Jul-2015  Views: 2961

Pharma major Lupin Limited has acquired a US-based privately held research-oriented generic company Gavis Pharmaceuticals LLC and Novel Laboratories I ...
Mylan boosts offer to Buy Perrigo to $34.1 Billion

Mylan boosts offer to Buy Perrigo to $34.1 Billion

News | Pharma Companies
Date:
30-Apr-2015  Views: 2771

Generic drugmaker Mylan raised its offer for over-the-counter medicines maker Perrigo Wednesday, but the Irish company again rejected Mylan's overture ...
Teva Offers to acquire Mylan for $40 billion in cash, stock

Teva Offers to acquire Mylan for $40 billion in cash, stock

News | Pharma Companies
Date:
30-Apr-2015  Views: 8104

Israeli pharma major Teva on Tuesday offered to acquire US-based Mylan in a deal estimated to be around $40 billion in cash and stock. ...
Mylan Inc to acquire Famy Care's businesses for $800 mn

Mylan Inc to acquire Famy Care's businesses for $800 mn

News | Pharma Companies
Date:
05-Feb-2015  Views: 1011

Mylan Inc will acquire certain businesses of Mumbai-based Famy Care Ltd, a specialty women's health care company, for a total consideration of $800 mi ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

82  + 9 =     
Comments

Google : 55 times | Yahoo : 12 times | Bing : 6 times |